Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 2 |
2016 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
gaeshin park[Author]
(58 results)?
Inhibition of Adipogenesis by Oligonol through Akt-mTOR Inhibition in 3T3-L1 Adipocytes.
Evid Based Complement Alternat Med. 2014;2014:895272. doi: 10.1155/2014/895272. Epub 2014 Sep 11.
Evid Based Complement Alternat Med. 2014.
PMID: 25295069
Free PMC article.
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects.
Hwang IG, Kang JH, Oh SY, Lee S, Kim SH, Song KH, Son C, Park MJ, Kang MH, Kim HG, Lee J, Park YS, Sun JM, Kim HJ, Kim CK, Yi SY, Jang JS, Park K, Kim HJ.
Hwang IG, et al. Among authors: park mj, park ys, park k.
Support Care Cancer. 2016 Jan;24(1):301-309. doi: 10.1007/s00520-015-2783-9. Epub 2015 Jun 4.
Support Care Cancer. 2016.
PMID: 26041481
Clinical Trial.
Item in Clipboard
Oligonol suppresses lipid accumulation and improves insulin resistance in a palmitate-induced in HepG2 hepatocytes as a cellular steatosis model.
Park JY, Kim Y, Im JA, Lee H.
Park JY, et al.
BMC Complement Altern Med. 2015 Jun 16;15:185. doi: 10.1186/s12906-015-0709-1.
BMC Complement Altern Med. 2015.
PMID: 26077338
Free PMC article.
Item in Clipboard
Cite
Cite